Recombinant Viral B18R Protein, CF

Images

 
The viral type I IFN receptor, B18R, inhibits the anti-viral activity of Recombinant Human IFN-alpha 2. The ED50 for this effect is 0.3-1.8 ng/mL.

Product Details

Summary
Reactivity VSpecies Glossary
Applications Bioactivity
Format
Carrier-Free

Order Details

Recombinant Viral B18R Protein, CF Summary

Additional Information
Type I IFN Inhibitor
Details of Functionality
Measured by its ability to inhibit Type-I IFN-mediated anti-viral activity. Symons, J.A. et al. (1995) Cell 81:551. The ED50 for this effect, as measured by inhibition of Recombinant Human IFN‑ alpha 2 (Catalog # 11105-1) , is 0.3-1.8 ng/mL.
Source
Human embryonic kidney cell, HEK293-derived viral B18R protein
MD Human IgG1
(Pro100-Lys300)
IEGR Viral B18R
(His20-Glu351)
Accession # P25213
N-terminus C-terminus
Accession #
N-terminal Sequence
Met-Asp-Pro100
Structure / Form
Disulfide-linked homodimer
Protein/Peptide Type
Recombinant Proteins
Gene
B19R
Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<0.10 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

Dilutions
  • Bioactivity
Theoretical MW
65 kDa (monomer).
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
80-95 kDa, reducing conditions
Publications
Read Publications using
8185-BR in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS.
Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Reconstitution Instructions
Reconstitute at 500 μg/mL in PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Viral B18R Protein, CF

  • B18R

Background

B18R (Soluble IFN alpha/beta receptor B18) is a 60-65 kDa protein encoded by the Vaccinia virus genome and by the genomes of other orthopoxviruses. Its function represents one of several mechanisms used by these viruses to evade the host immune response (1, 2). It is known as B18R in the Western Reserve (WR) strain of Vaccinia but as B19R in the Copenhagen strain (3). There is a structurally-unrelated, larger Vaccinia protein that is also known as B18R (or B16R) that contains multiple ankyrin-like repeats (4). The soluble IFN receptor B18R, however, contains three immunoglobulin-like domains and shows homology to human, mouse, and bovine type I IFN receptors (5). The Wyeth strain of Vaccinia virus encodes a truncated protein that lacks the C-terminal Ig-like domain, and B18R is functionally absent in the Lister strain (6, 7). B18R functions as a decoy receptor for type I IFNs (IFN alpha, beta, omega). It binds to type I IFNs from multiple species and prevents IFN signaling through its receptors (6-8). B18R binds to the surface of virus infected and uninfected cells where it retains its capacity to bind and neutralize IFN (6, 8). It shields those cells from the antiviral effects of type I IFNs, thereby enabling virus replication and pathogenicity (6-8). B18R also limits the effectiveness of IFN alpha produced following TLR activation (9), and it limits adaptive T cell responses (3). The B18R viral protein also acts to protect cells during mRNA transfection to produce induced pluripotent stem cells (iPSCs) from somatic cells (10). The addition of B18R results in increased cell viability of iPSCs in the presence of modified synthetic mRNAs such as OCT4, SOX2, KLF4, MYC, NANOG, and LIN28A. Using mRNAs in combination with B18R allows for integration-free reprogramming of somatic cells to iPSCs without the use of viral vectors or genomic modification.
  1. Smith, G.L. et al. (2013) J. Gen. Virol. 94:2367.
  2. Perdiguero, B. and M. Esteban (2009) J. Interferon Cytokine Res. 29:581.
  3. Gomez, C.E. et al. (2012) J. Virol. 86:5026.
  4. Goebel, S.J. et al. (1990) Virology 179:247.
  5. Smith, G.L. and Y.S. Chan (1991) J. Gen. Virol. 72:511.
  6. Alcami, A. et al. (2000) J. Virol. 74:11230.
  7. Symons, J.A. et al. (1995) Cell 81:551.
  8. Colamonici, O.R. et al. (1995) J. Biol. Chem. 270:15974.
  9. Waibler, Z. et al. (2009) J. Virol. 83:1563.
  10. Warren, L. et al. (2010) Cell Stem Cell. 7:618.

Publications for B18R (8185-BR)(5)

We have publications tested in 2 confirmed species: Human, Mouse.

We have publications tested in 2 applications: Bioassay, Neutralization.


Filter By Application
Bioassay
(4)
Neutralization
(1)
All Applications
Filter By Species
Human
(5)
Mouse
(1)
All Species
Showing Publications 1 - 5 of 5.
Publications using 8185-BR Applications Species
García, M;Carrasco García, A;Weigel, W;Christ, W;Lira-Junior, R;Wirth, L;Tauriainen, J;Maleki, K;Vanoni, G;Vaheri, A;Mäkelä, S;Mustonen, J;Nordgren, J;Smed-Sörensen, A;Strandin, T;Mjösberg, J;Klingström, J; Innate lymphoid cells are activated in HFRS, and their function can be modulated by hantavirus-induced type I interferons PLoS pathogens 2024-07-01 [PMID: 39038044] (Bioassay, Human) Bioassay Human
Lodge, R;Xu, Z;Eklund, M;Stürzel, C;Kirchhoff, F;Tremblay, MJ;Hobman, TC;Cohen, ÉA; MicroRNA-25/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages mBio 2023-09-29 [PMID: 37773002] (Bioassay, Human) Bioassay Human
Q Chen, M Coto-Llere, A Suslov, RD Teixeira, I Fofana, S Nuciforo, M Hofmann, R Thimme, N Hensel, V Lohmann, CKY Ng, G Rosenberge, S Wieland, MH Heim Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses Nature Communications, 2021-08-12;12(1):4882. 2021-08-12 [PMID: 34385466] (Bioassay, Human) Bioassay Human
T Imamichi, S Goswami, X Hu, S Laverdure, J Yang, J Qiu, Q Chen, BT Sherman, W Chang MicroRNA Profiles in Monocyte-Derived Macrophages Generated by Interleukin-27 and Human Serum: Identification of a Novel HIV-Inhibiting and Autophagy-Inducing MicroRNA International Journal of Molecular Sciences, 2021-01-28;22(3):. 2021-01-28 [PMID: 33525571] (Neutralization, Human) Neutralization Human
CD Swaim, LA Canadeo, KJ Monte, S Khanna, DJ Lenschow, JM Huibregtse Modulation of Extracellular ISG15 Signaling by Pathogens and Viral Effector Proteins Cell Rep, 2020-06-16;31(11):107772. 2020-06-16 [PMID: 32553163] (Bioassay, Human, Mouse) Bioassay Human, Mouse

Reviews for B18R (8185-BR) (0)

There are no reviews for B18R (8185-BR). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for B18R (8185-BR) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional B18R Products

Blogs on B18R

There are no specific blogs for B18R, but you can read our latest blog posts.

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Viral B18R Protein, CF and receive a gift card or discount.

Bioinformatics

Gene Symbol B19R
Uniprot